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Abstract: Although the human parainfluenza virus 4 (HPIV4) has been known for a long 
time, its genome, alone among the human paramyxoviruses, has not been completely 
sequenced to date. In this study we obtained the first complete genomic sequence of 
HPIV4 from a clinical isolate named SKPIV4 obtained at the Hospital for Sick Children in 
Toronto (Ontario, Canada). The coding regions for the N, P/V, M, F and HN proteins show 
very high identities (95% to 97%) with previously available partial sequences for HPIV4B. 
The sequence for the L protein and the non-coding regions represent new information.  
A surprising feature of the genome is its length, more than 17 kb, making it the longest 
genome within the genus Rubulavirus, although the length is well within the known range 
of 15 kb to 19 kb for the subfamily Paramyxovirinae. The availability of a complete 
genomic sequence will facilitate investigations on a respiratory virus that is still not 
completely characterized. 
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1. Introduction 
Human parainfluenza viruses are enveloped, negative strand RNA viruses belonging to the family 
Paramyxoviridae, and which cause respiratory tract infections. The two species human parainfluenza 1 
(HPIV1) and human parainfluenza 3 (HPIV3) belong to the genus Respirovirus, whereas HPIV2   
and HPIV4 belong to the genus Rubulavirus. Among the known human paramyxoviruses, the genome 
of HPIV4 has not yet been completely sequenced. The species HPIV4 is further divided into types 
HPIV4A and HPIV4B, based on antigenic differences demonstrated by hemadsorption inhibition and 
monoclonal antibody reactivity [1]. 
In this study the first complete genomic sequence of a HPIV4 was determined. It was based on a 
clinical isolate, designated SKPIV4, that was shown to be a HPIV4B by direct immunofluorescence 
microscopy and sequencing of the nucleocapsid (N) gene. The availability of this first complete 
sequence of HPIV4 fills an important gap in our knowledge of the Paramyxoviridae family and 
contributes to a complete description of the human virome. 
2. Results 
2.1. Identification of the respiratory virus isolate SKPIV4 as a HPIV4 
The isolate of HPIV4 was recovered from the nasopharyngeal swab taken from a patient at the 
Hospital for Sick Children. The presence of a growing virus was first inferred from a positive 
hemadsorption reaction. Immunofluorescence microscopy on a cell pellet from the culture was 
negative using monoclonal antibodies (Mabs) against Influenza A and B and against HPIV1, HPIV2, 
and HPIV3. Electron microscopy examination of a cell pellet revealed the presence of characteristic 
nucleocapsids from paramyxoviruses (Figure 1). Immunofluorescence microscopy with an anti-HPIV4 
Mab revealed the expected intracytoplasmic staining of cells infected with HPIV4 (Figure 2).  
2.2. Amplification and sequencing of the viral genome 
Primers to amplify large overlapping amplicons spanning most of the viral genome (Figure 3) were 
designed based on conserved regions in the sequence of paramyxoviruses, or from the existing partial 
sequence data available for HPIV4 in GenBank. The sizes of the amplicons are given in Table 1. The 
sequences of the genomic termini were determined by RNA ligase circularization of the genome 
followed by RT-PCR of an amplicon bracketing the junction, and by 5’ RACE. Additional 
experiments described in section 3.11 further confirmed the sequence. After assembly and editing, the 
complete sequence of SKPIV4 had a length of 17361 nts, and was deposited in GenBank under the 
accession number EU627591. 
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Figure 1.  Electron microscopy photograph obtained from LLC-MK2 cells infected with 
SKPIV4, showing typical nucleocapsids of paramyxoviruses. 
 
 
Figure 2.  Immunofluorescence microscopy  after permeabilisation, fixation and staining 
with FITC labeled anti HPIV4 Mab 5034 (Chemicon). Panel A, uninfected LLC-MK2 
cells; Panel B, cells infected with the isolate SKPIV4. 
            
     A        B  
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Figure 3.  Schematic illustration of the HIPV4 genome and the relative positions of the 
amplicons obtained by long RT-PCR that were used in sequencing the SKPIV4 genome. 
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Table 1.  Primers used in long RT-PCR to generate the amplicons illustrated in Figure 1; 
the lengths of the amplicons are also listed. 
PCR 
amplicon  Primer  Primer Sequence (5’ 3’) 
Size 
(bp) 
a  Para4-1 
Para4-2 
CGAACAATTTCTTCAAACAACTGAAGATCG 
CTGTTCATTCTGATAGTTGGAGTCTGGTGTG  1,438 
b 
LongPara-P1 GGTTGCATTCAGGTTTCTCAATCGTTCAGGC 
3,138 
LongPara-M2 GCCCCCATAGATCACTGATGCCTACGCTTAAC 
c 
LongPara-M1 CCGATCCACACGAATGAGGGGTATACATCTAGAG 
4,266 
LongPara-HN2 CGTAAGGAGTGACGAATGTGAGTGGGTAAGACGAAC 
d 
LongPara-HN1 GCTCAGTGGTTGCTGTCCTTGACGGATGTTTAC 
3,545 
LongPara-2 GGAGTGATTTCGTCAACTTAAGCTGATCAAGAACTACACCG 
e 
LongPara-L1 GGAGATACCAAGCAATAATACCCTTTGCTAGAAC 
3,013 
LongPara-L4 GCTGTTACATGGATAAGGATGTATATTTGGGTTTG 
f 
LongPara-L5 TAGCTGTGCAATGTCTCATGTGGGGCGTTAAAACC 
1,733 
LongPara-L6 GTCGTACAGTATCCCGGATTGAACTGCGTAAAACTCACC 
2.3. The Nucleocapsid (N) gene 
The first coding region in the genome contains a single ORF (155 to 1,810) encoding for the 
nucleocapsid. BLAST analysis showed a 97% identity to a previously determined sequence for the 
nucleocapsid gene of a HPIV4B (89% with HPIV4A), with a 98% identity at the amino acid (a.a) level 
(92% with HPIV4A) [2]. Figure 4 shows a phylogenetic tree calculated from an alignment of the 
sequences of the nucleocapsid ORF from several paramyxoviruses, including previously determined 
sequences from HPIV4A and HPIV4B isolates. Figure 4 shows conclusively that the SKPIV4 isolate 
should be classified as a HPIV4B. 
2.4. The Phosphoprotein/V-protein (P/V) gene 
The next coding region, P/V, from nts 2,096 to 3,293, contains potentially two ORFs through the 
addition of non-templated G residues to the mRNA [3]. Overall, BLAST analyses revealed a 96% 
identity with the corresponding coding region of a HPIV4B isolate (87% with HPIV4A), with a 100% 
identity within the region where insertion of non-templated Gs occur during mRNA synthesis [3]. 
Based on the postulated translation of these proteins, BLAST analysis revealed a 93% identity of the P 
protein at the a.a level between SKPIV4 and that of Kondo et al (84% with HPIV4A), and a 92% 
identity at the a.a. level for the V protein (81% with HPIV4A) [3]. Viruses 2009, 1 
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Figure 4.  Phylogenetic tree built from an alignment of the nucleocapsid (N) ORF 
nucleotide sequence of several paramyxoviruses. The numbers at the nodes indicate the 
results of the Bootstrap analysis, expressed as percentages. The N ORF sequences were 
excerpted from the complete genomic sequence for Rinderpest virus (GenBank accession 
number NC_006296), Measles virus (AY486083), Canine Distemper virus (AY649446), 
Nipah virus (AY988601), Hendra virus (NC_001906), Human Parainfluenza  virus 3 
(EU424062), Sendai Virus (NC_001552), Human Parainfluenza virus 1 (NC_003461), 
Newcastle Disease virus (DQ486859), SV5 (NC_006430), Human Parainfluenza virus 2 
(NC_003443), Mumps virus (AF314558). The GenBank accession numbers for the N gene 
sequences of Human Parainfluenza 4A and 4B are M32982 and M32983, respectively. 
 
 
2.5. The Matrix (M) gene 
The ORF for the matrix (M) protein goes from nts 3,589 to 4,737. By BLAST analyses it has a 96% 
identity with the previously reported M gene for HPIV4B (89% with HPIV4A)[4]. At the a.a. level, an 
identity of 97% is observed (95% with HPIV4A). 
2.6. The Fusion (F) gene 
An ORF for the F coding gene was found to extend from nts 5,232 to 6,863. By BLAST analyses 
the corresponding sequence has a 96% homology to the sequence of HPIV4B previously published 
(90% with HPIV4A) [5], with an identity of 97% at the a.a. level (94% with HPIV4A). 
2.7. The Haemagglutinin-Neuraminidase (HN) gene 
An ORF for the HN gene was found extending from nts 7,563 to 9,302. This sequence has a 95% 
identity to the previously reported sequence for a HPIV4B isolate (GenBank AB006958), with an 
identity of 92% at the a.a. level, although the predicted protein of SKPIV4 is longer by 5 a.a at the Viruses 2009, 1 
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carboxy terminal. Comparison with previously determined sequences of HPIV4A shows identities of 
86%, and 84% at the a.a. level [6]. 
2.8. The Large (L) gene 
The ORF coding for the large (L) protein of SKPIV4 spans nts 10025 to 16864, accounting for 
approximately 39% of the total genome. To date, this gene has not been sequenced for HPIV4. BLAST 
analyses of the nucleotide sequence failed to generate a significant match using the MEGABLAST 
program with standard parameters; the BLASTN program revealed several large segments with 
homology ranging from 66% to 70% with the L gene of mumps virus, and 65% to 68% with that of 
HPIV2. At the amino acid level, the predicted protein has 53% identity with the L protein of the 
mumps virus, with a BLAST score of 2,505; the second best match is with SV5 (52%; 2,431), 
followed by HPIV2 (51%; 2352). Figure 5 displays the phylogenetic tree calculated from an alignment 
of the L ORF sequence of SKPIV4 and the sequences of several paramyxoviruses. 
Figure 5.  Phylogenetic tree built from an alignment of the Large (L) protein ORF 
sequences of several paramyxoviruses. The numbers at the node indicate the results of the 
Bootstrap analysis, expressed as percentages. The L ORF sequences were excerpted from 
the complete genome sequences listed in the legend of Figure 4. 
 
 
2.9. The genomic termini 
In order to determine the sequence of the termini, including the non coding regions, the genomic RNA 
was circularized using RNA ligase; the purified circular RNA was then subjected to RT-PCR using 
one primer anchored in the N coding region and the other in the L coding region.The RT-PCR yielded 
an amplicon of approximately 1.5 kb, containing the complete non coding terminal regions and the site 
of junction sealed by the RNA ligase. The amplicon was completely sequenced on both strands. Viruses 2009, 1 
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To determine precisely the site of the junction between the ends of the genome, the sequence was 
examined for the type of extensive identity between the 3’ ends of the genome and antigenome 
exemplified by many paramyxoviruses [7], for example HPIV2 (Figure 6). This inspection led to a 
tentative identification of the junction site (Figure 6). To corroborate this hypothesis, a RT-PCR using 
primers Lend-1 and Lend-2 (Table 2) was done and, as predicted, yielded an amplicon of the expected 
length upstream of the junction. The final demonstration consisted in performing a 5’ RACE using 
primers 5RACE-1, 5RACE-2 and the primer supplied in the 5’ RACE kit. The sequence of the 
amplicon obtained by 5’ RACE showed the junction to be exactly as postulated in Figure 6. 
Figure 6.  Top panel: hypothesized junction site of the extremities of SKPIV4 after RNA 
ligation and RT-PCR. Bottom panel: predicted junction site of the extremities of HPIV2 
(NC_003443) after RNA ligation and RT-PCR. 
SKPIV4
TTTCCCCTTGGTACCAAGGGGAGA
AAAGGGGAACCATGGTTCCCCTCT
HPIV2
TCTCCCCTTGGTAAGGGGAGAAGA
AGAGGGGAACCATTCCCCTCTTCT
SKPIV4
TTTCCCCTTGGTACCAAGGGGAGA
AAAGGGGAACCATGGTTCCCCTCT
HPIV2
TCTCCCCTTGGTAAGGGGAGAAGA
AGAGGGGAACCATTCCCCTCTTCT
 
 
Table 2. Primes used in the sequence determination of the extremities of the viral genome. 
Primers Para-GRacerLS and Para-GRacer-NRS were used to synthesize by RT-PCR the 
amplicon containing the junction (see Figure 6). 
Primer  Primer Sequence (5’ 3’) 
ParaGRacer-LS 
ParaGRacer-NRS 
CTGATAATCAAAAGATCCTACAAGCAGGTGG 
CAGATGATGATACGGCAAGTCGGAGG 
  
LEnd-1 CTTTAGAAATGAATGAGCAAGTAGTCG 
LEnd-2 CAGATTTGTCTAGTGAGGATGTTGTC 
  
GSP1-v.2 GAAAGATACGGAGACGAGACAAC 
GSP2-v.2 CAACATCCTCACTAGACAAATCTG 
  
Primers Lend-1 and Lend-2 were used in a RT-PCR predicted to yield an amplicon 
upstream of the junction; these data allowed the design of the primers used in the 
5’ RACE; Primers 5RACE-1 and 5RACE-2 were used, along with the AAP primer 
(Invitrogen) in the 5’ RACE reaction. 
 
3. Material and methods 
3.1. Source of the HPIV4 strain 
The virus was isolated from a nasopharyngeal swab submitted to the Clinical Virology laboratory of 
the Hospital for Sick Children (Toronto) for respiratory viruses detection. Viruses 2009, 1 
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3.2. Isolation and culture 
The isolate was initially grown in primary rhesus monkey kidney cells as described [9]. The 
presence of the virus was demonstrated by hemadsorption with guinea pig erythrocytes. The virus was 
subsequently passaged in LLC-MK2 cells (American Type Culture Collection, Manassas, Virginia). 
Passage 5 stock was used for RNA extraction and sequencing. 
3.3. Immunofluorescence microscopy 
Detection of respiratory virus antigens was done by direct immunofluorescence microscopy. 
Briefly, cells were pelleted in a microfuge at 12,000 g for 3 min and resuspended in 100 L of 
phosphate buffered saline (PBS). Five L aliquots were spotted on a multi-well glass slide, air-dried 
and fixed with cold acetone. Wells were stained with different labeled monoclonal antibodies specific 
for influenza A, influenza B, parainfluenza 1,2,3 (Chemicon, Temecula, Ca). For the detection of 
parinfluenza 4, the parainfluenza 4 antibody FITC reagent (Parainfluenza 4: antibody FITC conjugate 
“Ready to Use” Reagent; Chemicon #5034) was used according to the manufacturer’s 
recommendations. 
3.4. Electron microscopy 
A cell suspension was obtained by scraping an infected cell monolayer with a sterile loop. The 
suspension was centrifuged for 2 min in a microfuge at 12,000 g, the supernatant discarded and the 
pellet resuspended in 1% ammonium acetate. Five L of the suspension were applied to a Formvar and 
carbon coated electron microscopy grid and stained with 2% phosphotungstic acid, as described [10]. 
The grids were examined with a JEOL 1010 electron microscope at a magnification of 50,000 . 
3.5. Extraction of viral RNA 
Total RNA was extracted from aliquots of cell suspensions collected from culture infected with the 
parainfluenza 4 isolate (SKPIV4), using the TRIzol reagent (Invitrogen, Burlington, Ontario, Canada) 
as per the manufacturer’s recommendations. The RNA pellets were resuspended in ddH2O containing 
10% of 100mM dithiotreitol (Invitrogen) and 5% of 20-40 U/l RNasin (Promega, Mississauga, 
Ontario), and stored at -80 C. 
3.6. Primer design for long RT-PCR 
Primers used in the long RT-PCR were designed using Gene Runner v3.05 (Hasting Software), 
based on the sequences of HPIV4 (when available) and the sequences of other paramyxoviruses 
including HPIV1, HPIV2, HPIV3 and mumps virus.  
3.7. Long RT-PCR 
Long RT-PCR was done essentially as described [11, 12], with an elongation time optimized for 
each amplicon. Figure 3 illustrates the position of the overlapping amplicons that span the HPIV4 
genome. Table 1 lists the sequence of the primer pairs used and the size of the corresponding 
amplicons. Viruses 2009, 1 
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3.8. RNA ligase mediated amplification of genome ends 
The viral genomes, contained in the purified RNA extracted from cells infected with SKPIV4, were 
circularized by ligating the ends with T4 RNA ligase; the resulting circular RNAs were then purified. 
This was done using the GeneRacer kit (Invitrogen) as per the manufacturer’s instructions. The 
purified circularized viral RNA was then subjected to long RT-PCR, using the primers Para-GRacer-
LS and Para-GRacer-NRS (Table 2). The resulting amplicon was then sequenced. 
3.9. 5’ RACE 
The 5’ RACE System procedure (Invitrogen) was used to determine sequence of the viral 
(genomic) RNA at the 5’ end, as per the manufacturer’s recommendations. Briefly, the single strand 
cDNA was synthesized using Superscript II reverse transcriptase and the primer 5RACE-1 (Table 2). 
The cDNA was then purified using the S.N.A.P. column followed by TdT tailing of the cDNA as per 
the manufacturer’s protocol. Five uL of the resulting dC-tailed cDNA was used as template in a PCR 
reaction consisting of 2 μL of primer 5RACE-2 (10 μM) and the supplied primer AAP, 5 μL of 10X 
PCR buffer, 5 μL of 25 mM MgCl2, 1 μL of deoxynucleoside triphosphate (200 μM), 0.5 μL of 
AmpliTaq Gold (Applied Biosystems Inc.), and 29.5 μL of molecular grade dd H2O.  PCR was carried 
out in a Robocycler 40 thermal cycler (Stratagene) starting with one cycle consisting of denaturation at 
94ºC for 10 min, annealing at 53ºC for 1 min and elongation at 72ºC for 1 min 30 s, followed by 35 
cycles at 94ºC for 1 min, 53ºC for 1 min, 72ºC for 1 min 30s. The PCR product (375 bp) was 
submitted to sequencing. 
3.10. Sequencing of amplicons 
Amplicons from PCR reactions were subjected to electrophoresis on agarose gels containing the 
GelStar nucleic acid dye (Cambrex) and visualized on a Dark Reader transilluminator (Clare 
Chemical). Amplicons were sent to ACGT Corporation, (Toronto, Canada) for automated sequencing 
of both strands using ad hoc sequencing primers designed from previously obtained sequencing data. 
Initial reactions were done using the PCR primers. 
3.11. Corroboration of the sequence 
Additional PCRs and experiments were done to confirm the sequence of non-coding regions and of 
the L gene. Based on the complete sequence obtained, new primers were designed to amplify the non-
coding regions between the ORFs and the amplicons were sequenced on both strands. The ORF coding 
for the L protein was completely re-sequenced with a different set of primers and overlapping 
amplicons. RT-PCRs targeting the non-coding genomic termini using primers at the very ends and 
primers within the N and L ORFs were done and the amplicons sequenced. The genomic RNA ligation 
was repeated using RNA from passage 4 infected cells. The 5’ RACE was repeated using RNA 
extracted from culture supernatant of passage 5 cells. 
 
 
 Viruses 2009, 1 
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3.12. Sequence assembly and analysis 
The individual sequence fragments were aligned and assembled using Gene Runner v. 3.05 
(Hasting Software); editing was done using Gene Runner and Genedoc v 2.3 (distributed by Nicholas 
K.B. and Nicholas H.B.). Sequence alignments were calculated using ClustalX for Windows v.1.81 
[13] . The GenBank database was interrogated using the BLASTN and BLAST search programs [14, 
15]. Phylogenetic trees were inferred by using TREECON for Windows v.1.3b [16] using a distance 
method. The distance was calculated without corrections, taking gaps into account; the tree topology 
was inferred by the neighbor-joining method, and the trees were re-rooted at the internode. Bootstrap 
analyses were done with 1000 replicates. 
4. Discussion 
Among the known human paramyxoviruses, only the genome of HPIV4 had not been completely 
sequenced. The isolation of a HPIV4 from a clinical sample prompted the determination of the 
complete sequence, undertaken in this study. 
The strategy used in the present study to assemble the full length HPIV4 genome, which involved  
overlapping large amplicons obtained by long RT-PCR and direct sequencing of the amplicons, 
provides some theoretical advantages over cloning in E.coli and sequencing clones, including 
obtaining directly the consensus sequence, and avoiding selection bias because of toxicity of some 
viral sequences to E.coli [17, 18]. 
The isolate used here was first identified as a paramyxovirus by electron microscopy, and as a 
HPIV4 by immunofluorescence microscopy. It was further typed as a HPIV4B by sequencing of the N 
gene and phylogenetic analysis (Figure 4); this was further confirmed by sequencing of the P/V, M, F 
and HN coding regions. 
Among the subfamily Paramyxovirinae, the P/V region encodes for more than one protein (the 
number varies between virus species), in part through the mechanism of non-templated addition of G 
residues at the time of viral mRNA synthesis [1]. HPIV1 and HPIV3 encode the P protein through 
faithful mRNA transcription, and encode the V protein through non-templated insertion of G residues. 
In contrast, mumps virus and HPIV2 encode the V protein through faithful RNA transcription and the 
P protein through non-templated insertion. For HPIV4, Kondo et al. [3] performed direct  mRNA 
cloning and sequencing and showed that HPIV4A and HPIV4B followed the strategy of the other 
rubulaviruses, encoding the P protein through non-templated  insertion . Although viral mRNA 
purification from infected cells followed by cloning and sequencing was not carried out in this study, 
because of the identity of the sequences at the site where RNA editing would occur it is predicted that 
the isolate SKPIV4 sequenced here would behave in the same way. 
The a.a. sequence for the HN protein of SKPIV4 is highly homologous to that reported by Bando et 
al., although it has five additional a.a. at the carboxy terminal. This is reminiscent of the finding of 
Sakaguchi et al [19], who reported that isolates of Newcastle disease virus (NDV) could be classified 
into three subgroups based on the different sizes of the HN protein caused by additional a.a. at the 
carboxy terminal and corresponding to three different viral lineages. This grouping correlated 
somewhat with virulence, although other determinants also play a role [19]. Viruses 2009, 1 
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The L gene sequence presented here is the first ever determined for a HPIV4. The nucleotide 
sequence is unique, but shows significant homology with the L sequence of other rubulaviruses. The 
phylogenetic tree obtained from an alignment of the L gene sequences (Figure 5) displays essentially 
the same topology as the tree from the alignment of the N gene sequences (Figure 4). 
The L protein of paramyxoviruses is a very large protein with several enzymatic activities, including 
RNA directed RNA polymerase, 5’ end capping and methylation, and 3’ end poyladenylation. The L 
protein is involved not only in the synthesis of viral mRNAs but also in the synthesis of the 
antigenome and of the genome, these latter activities being dependent on the presence of soluble N 
proteins [1]. The L protein comprises 6 domains that are highly conserved among paramyxoviruses, 
and which are thought to contain the sites responsible for the enzymatic activities [8, 20, 21]; in 
particular, domain II has been proposed as a RNA binding domain, domain III as containing a 
conserved GDNQ motif involved in nucleotide polymerisation, and domain VI as involved in 5’ CAP 
formation [1]. Using the boundaries of the six domains in the L protein that were delineated for the 
mumps virus [8], it can be seen that within these domains there is very strong homology between the L 
protein of mumps virus and of SKPIV4 (Figure 7). 
In this study the noncoding extremities of the HPIV4 genome were also sequenced, through ligation 
of the viral genome ends and RT-PCR. The junction sequence that was postulated by inspection of the 
sequence (Figure 6) and through comparison with the sequence of HPIV2 and the known 
complementarity of both ends of the genome was demonstrated to be correct through the use of the 5’ 
RACE procedure. A comparison with the ends of the genome of HPIV2 (or even of mumps) suggests 
that an additional ACC should be present at the 5’ end of the antigenome; further, such an addition 
would put the length of the complete genome at 17,364 nts, consistent with the “rule of six” [1]. It may 
be argued that since the sequence reported here is a consensus sequence determined by direct 
sequencing of amplicons, the complete, undamaged sequence could be present only in a minority of 
molecules and not be detected unless cloning and sequencing of many clones is performed. However, 
the addition of a ACC group would create a Kpn I restriction site at the junction (Figure 6); digestion 
of the amplicon with Kpn I failed to show even a partial digestion (data not shown), suggesting that if 
amplicons with the ACC group existed, they were indeed very rare and would require the sequencing 
of a very large number of clones to be detected.  
The “rule of six” was initially formulated based on observations made on the Sendai virus [1]. Other 
studies using subgenomic replicons or defective interfering particles (DIs) of SV5, HPIV3 and 
Newcastle disease virus have shown that for subgenomic replicons, adherence to the rule of six was 
not essential, although polyhexameric length was associated with a greater replicative efficiency [22-
24]. Despite the fact that most sequences of HPIV2 have a polyhexameric length, the reported 
sequence of the Toshiba strain (GenBank NC_003443) had a length of 15,646 nts; transfection of non 
polyhexameric cDNAs based on this strain yielded infectious HPIV2 virions [25] although the 
genomes of the progeny virions were not completely re-sequenced. A systematic investigation of this 
issue was undertaken by Skiadopoulos et al [26]; they found that non-polyhexameric full length cDNA 
clones reliably yielded infectious progeny viruses after transfection, but sequencing of the resulting 
genomes demonstrated the acquisition of compensatory mutations (insertions or deletions) that made 
the genomes compliant with the rule of six. Thus, even if the “rule of six” is not as stringent as initially 
formulated, it remains nonetheless a powerful constraint on the genomes of the subfamily Viruses 2009, 1 
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Paramyxovirinae. It is possible that the isolate sequenced in this study would have lost some nts by 
passage 4 and 5; it is also possible that our experimental approach failed to capture some nts at the 
termini, possibly through damage prior to ligation. Based on sequence comparison with other 
rubulaviruses, it would seem likely that an additional “ACC” at the 5’ end of the antigenome would be 
present in the “complete” sequence of HPIV4B. The final elucidation of this point may have to await 
for reverse genetics experiments [26]. 
Figure 7 Alignment of the a.a. sequences of the L proteins of mumps virus and SKPIV4, 
within the 6 conserved domains of the L protein [8]. 
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Another surprising characteristic of the sequence is its length; at 17,361 nts it is the largest known 
genome within Rubulavirus. A comparison of the ORFs of SKPIV4 with that of other rubulaviruses 
(Table 3) shows that overall SKPIV4 tends to have longer ORFs than other rubulaviruses, but not by 
very much. 
Table 3. Comparison of ORF lengths between SKPIV4 and some rubulaviruses. For each 
ORF the length (including the stop codon) is given in nt; the length of the corresponding 
protein, in a.a., is given in parenthesis. 
ORF SKPIV4  HPIV4B  HPIV4A  Mumps  HPIV2 
N 1656 
(551) 
1656 
(551) 
1656 
(551) 
1650 
(549) 
1629 
(542) 
P/V 
P
1 
V 
1198 
(399) 
(229) 
1198 
(399) 
(229) 
1198 
(399) 
(229) 
1174 
(391) 
225) 
1186 
(395) 
226) 
M 1149 
(382) 
1149 
(382) 
1149 
(382) 
1128 
(375) 
1134 
(377) 
F 1632 
(543) 
1632 
(543) 
1632 
(543) 
1617 
(538) 
1656 
(551) 
HN 1740 
(579) 
1725 
(574) 
1722 
(573) 
1749 
(582) 
1716 
(571) 
L 6840 
(2279) 
N/A N/A  6786 
(2261) 
6789 
(2262) 
Source of sequences; SKPIV4, GenBank EU627591; HPIV4A and HPIV4B, [2-6] 
and GenBank AB006958; Mumps virus, GenBank AF314558; HPIV2; GenBank 
NC_003443; 
1 For the P protein, the addition of two non-templated G residues 
occurs at the stage of mRNA synthesis. 
 
A comparison with previously known sequences of HPIV4B and HPIV4A shows that the ORFs 
have identical lengths, except for that of HN, which encodes an additional five amino acids. However, 
comparing the length of the non-coding intervals between SKPIV4 and HPIV2 (Table 4) shows that 
most of the difference between the length of the two genomes is accounted for by non-coding 
sequences. Although non-coding sequences of HPIV4A and HPIV4B were never completely 
determined previously, sequencing of various genes (from either mRNAs or genomic RNAs) 
contained partial or complete intervening sequences [2-6] which allows for a lower bound estimate of 
the length of non coding intervals. As is readily seen from Table 4, these estimates are remarkably 
consistent with the findings from SKPIV4. Thus, most of the features that contribute to the length of 
the HPIV4 genome have in fact been observed previously. 
Although HPIV4 has the longest genome within Rubulavirus, there are other viruses with larger 
genomes than HPIV2 or even HPIV4 within the subfamily Paramyxovirinae. For example, within the 
closely related genus Avulavirus, AMPV-6 has a genome of 16,236 nts (GenBank NC_003043); within 
the Henipavirus genus, Hendra and Nipah have genomes of 18,234 nts and 18,252 nts, respectively 
[27, 28]; two recently discovered paramyxoviruses still not ascribed to any genus, the J virus [29] and 
the Beilong virus [30], have even larger genomes of 18,954 nts and 19,212 nts, respectively. 
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Table 4. Comparison of the lengths, in nt, of the non-coding intervals between the ORFs, 
for SKPIV4 and several rubulaviruses. Source of sequences: as in Table 3. 
Non-coding 
interval 
SKPIV4 HPIV2  HPIV4B  HPIV4A 
5’ NC  154  156   33   33 
N-P/V 285  207   284  284 
P/V-M  295 300 294 294 
M-F 494  176   483   483 
F-HN  699 372 699 720 
HN-L 722  260   527   529 
3’ NC  497  65  N/A  N/A 
 
In summary, with the likely exclusion of a small number of nts at one genomic end, this study 
presents the first complete genomic sequence from a single isolate of HPIV4B. In particular, it 
presents the first available L gene sequence for a HPIV4, and the first sequence available for several 
non-coding regions. These data fill an important gap in our knowledge of the human paramyxoviruses 
and should facilitate molecular investigation of this relatively less studied human respiratory virus. 
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